(Q45874418)

English

Supplemental guidance on testing for replication-competent retrovirus in retroviral vector-based gene therapy products and during follow-up of patients in clinical trials using retroviral vectors

scientific article published in February 2001

Statements

Supplemental guidance on testing for replication-competent retrovirus in retroviral vector-based gene therapy products and during follow-up of patients in clinical trials using retroviral vectors (English)
0 references
0 references
Guidance for Industry, U.S. Department of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research (CBER).

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit